Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole adjunctive therapy for treatment-resistant bipolar depression
2018-002869-18Phase 3Unknown
- Sponsor
- Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar disorder (BD) comparing Pramipexole plus mood stabilisers with Placebo plus mood stabilisers (2 arms). Primary endpoint: Quick Inventory of Depressive Symptomatology – Self Report. Status: unknown.
02
Drugs
pramipexole
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on 2018-002869-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002869-18.